BSP Pharmaceuticals S.p.A. is proud to announce Its partecipation to the annual event of Neo-Synth: Precision Breast Cancer Summit of Boston. This is an exclusive, annual biopharma summit providing insights into the research and development of cutting edge treatments for Breast Cancer and a networking forum for precision medicine leaders in this space. The 'Precision Breast Cancer' Summit will be the next MARCH 6-7 2018 at The Royal Sonesta Hotel in Boston (USA). The Precision Breast Cancer Summit provides a unique networking opportunity to stakeholders across the R&D value chain to discuss key issues, and propose solutions to common challenges. The discussions will revolve around all the latest trends in personalized medicine, as pertaining to this disease area, through case studies from early stage of discovery to clinical development. The key topics of the Summit are:
Save the Date!!! During the Morning Session on Tuesday March 6th, from 9.00 AM to 10.30 AM, Giorgio Salciarini (Technical Business Development Manager) will be one of the speacker of the 'Antibody Drug Conjugates for Breast Cancer' panel.
To request a meeting, You can send an e-mail at email@example.com